Hamza Suria compensation by year
ANAPTYSBIO Summary Compensation Table · all 6 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|
| Salary | $425,000 | $465,000 | $547,000 | $567,000 | $567,000 | $586,000 |
| Bonus | $153,000 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $0 | $0 | $0 |
| Option awards | $0 | $3,341,588 | $4,303,927 | $7,301,646 | $0 | $2,702,323 |
| Non-equity incentive | $0 | $209,250 | $270,765 | $0 | $311,850 | $241,725 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $600 | $600 | $540 | $6,540 | $6,540 | $8,810 |
| Total | $578,600 | $4,016,438 | $5,122,232 | $7,875,186 | $885,390 | $3,538,858 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ANAPTYSBIO, INC DEF 14A filed April 29, 2022, accession 0001370053-22-000025, and prior-year filings.
How this page was built: the ANAPTYSBIO, INC filed document, accession 0001370053-22-000025. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.
Equity holdings
unvested awards at FY2021 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 27,417 | — | $68.89 |
| Option | 140,000 | — | $15.73 |
| Option | 46,300 | — | $29.70 |
| Option | 1,312 | — | $106.84 |
| Option | 119,700 | — | $29.70 |
Per the Outstanding Equity Awards at Fiscal Year-End table in ANAPTYSBIO, INC's FY2021 proxy; value at the fiscal year-end close, as the company printed it.
ANAPTYSBIO’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Hamza Suria · this page | President, Chief Executive Officer and Director | $3,538,858 |
| Paul Lizzul | Chief Medical Officer | $1,699,078 |
| Eric Loumeau | Chief Operating Officer and General Counsel | $1,655,786 |
The full ANAPTYSBIO compensation record
free company briefThis page is one person within ANAPTYSBIO's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the ANAPTYSBIO proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ANAPTYSBIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.